Increased Expression of GARP in Papillary Thyroid Carcinoma
Regulatory T cells (Tregs) are immunosuppressive immune cells that play an important role in tumor development. Suppression of Treg function is considered to be an effective strategy for cancer therapy. Glycoprotein A repetitions predominant (GARP) has been found on the surface of activated Tregs. GARP has been recently observed in only a few solid tumors including breast, colon, lung cancers, and melanoma. However, its function in cancers remains unknown. Here, we investigated the expression of GARP in human papillary thyroid carcinoma (PTC) and its prognostic significance. In this study, immunohistochemistry was performed to examine the expression of GARP and Foxp3 in 19 human PTC tissues (including 10 cases with and 9 cases without lymph node metastasis) and 20 benign thyroid diseases (including 10 cases with nodular goiter and 10 cases with adenoma). Compared with benign thyroid diseases, we found a significant increase in the expression of GARP in PTC. Increased GARP expression in PTC was positively correlated with increased expression of Foxp3, which is very important for development of Tregs. But, there is no significant association of elevated expression of GARP with lymph node metastasis in PTC. Our results indicate that GARP is implicated in the development of PTC and might be a potential novel target for anticancer therapy. In addition, our findings further support the existence of a positive-feedback loop between GARP and Foxp3.
KeywordsGARP Foxp3 Papillary thyroid carcinoma Thyroid Cancer
The authors thank Dr. Fengjie Qi for her confirmation of the pathological diagnosis of the patients. This study was supported by the high talent support program project of Jinzhou Medical University (2015RC011).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
The study was approved by the Ethics Committee of Jinzhou Medical University.
- 1.Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q. & He, J. (2016) Cancer statistics in China, 2015, CA: a cancer journal for clinicians. 66, 115–132.Google Scholar
- 2.Siegel, R. L., Miller, K. D. & Jemal, A. (2016) Cancer statistics, 2016, CA: a cancer journal for clinicians. 66, 7–30.Google Scholar
- 4.Davies, L., Morris, L. G., Haymart, M., Chen, A. Y., Goldenberg, D., Morris, J., Ogilvie, J. B., Terris, D. J., Netterville, J., Wong, R. J. & Randolph, G. (2015) American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: The Increasing Incidence of Thyroid Cancer, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 21, 686–696.CrossRefGoogle Scholar
- 10.Gavin, M. A., Torgerson, T. R., Houston, E., DeRoos, P., Ho, W. Y., Stray-Pedersen, A., Ocheltree, E. L., Greenberg, P. D., Ochs, H. D. & Rudensky, A. Y. (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development, Proceedings of the National Academy of Sciences of the United States of America. 103, 6659–6664.CrossRefGoogle Scholar
- 13.Ollendorff, V., Noguchi, T., deLapeyriere, O. & Birnbaum, D. (1994) The GARP gene encodes a new member of the family of leucine-rich repeat-containing proteins, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research. 5, 213–219.Google Scholar
- 14.Macaulay, I. C., Tijssen, M. R., Thijssen-Timmer, D. C., Gusnanto, A., Steward, M., Burns, P., Langford, C. F., Ellis, P. D., Dudbridge, F., Zwaginga, J. J., Watkins, N. A., van der Schoot, C. E. & Ouwehand, W. H. (2007) Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins, Blood. 109, 3260–3269.CrossRefGoogle Scholar
- 17.Tran, D. Q., Andersson, J., Wang, R., Ramsey, H., Unutmaz, D. & Shevach, E. M. (2009) GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3(+) regulatory T cells, Proceedings of the National Academy of Sciences of the United States of America. 106, 13445–13450.CrossRefGoogle Scholar
- 18.Wang, R., Wan, Q., Kozhaya, L., Fujii, H. & Unutmaz, D. (2008) Identification of a Regulatory T Cell Specific Cell Surface Molecule that Mediates Suppressive Signals and Induces Foxp3 Expression, Plos One. 3.Google Scholar
- 20.Miller, M. M., Fogle, J. E., Ross, P. & Tompkins, M. B. (2013) Feline glycoprotein A repetitions predominant anchors transforming growth factor beta on the surface of activated CD4(+)CD25(+) regulatory T cells and mediates AIDS lentivirus-induced T cell immunodeficiency, AIDS research and human retroviruses. 29, 641–651.CrossRefGoogle Scholar
- 22.Metelli, A., Wu, B. X., Fugle, C. W., Rachidi, S., Sun, S., Zhang, Y., Wu, J., Tomlinson, S., Howe, P. H., Yang, Y., Garrett-Mayer, E., Liu, B. & Li, Z. (2016) Surface Expression of TGFbeta Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer, Cancer research. 76, 7106–7117.CrossRefGoogle Scholar
- 23.Hahn, S. A., Neuhoff, A., Landsberg, J., Schupp, J., Eberts, D., Leukel, P., Bros, M., Weilbaecher, M., Schuppan, D., Grabbe, S., Tueting, T., Lennerz, V., Sommer, C., Jonuleit, H. & Tuettenberg, A. (2016) A key role of GARP in the immune suppressive tumor microenvironment, Oncotarget. 7, 42996–43009.CrossRefGoogle Scholar
- 24.Guo, M., Liu, C., Qi, F. J., Zhang, X. M., Ren, L. L., Liu, Y. M., Meng, Z. C., Zhu, Z. T. & Xiao, J. Y. (2014) Elevated expression of nuclear protein kinase CK2alpha as a poor prognosis indicator in lymph node cancerous metastases of human thyroid cancers, Asian Pacific journal of cancer prevention : APJCP. 15, 7425–7432.CrossRefGoogle Scholar
- 26.Probst-Kepper, M., Geffers, R., Kroger, A., Viegas, N., Erck, C., Hecht, H. J., Lunsdorf, H., Roubin, R., Moharregh-Khiabani, D., Wagner, K., Ocklenburg, F., Jeron, A., Garritsen, H., Arstila, T. P., Kekalainen, E., Balling, R., Hauser, H., Buer, J. & Weiss, S. (2009) GARP: a key receptor controlling FOXP3 in human regulatory T cells, Journal of cellular and molecular medicine. 13, 3343–3357.CrossRefGoogle Scholar
- 29.Bates, G. J., Fox, S. B., Han, C., Leek, R. D., Garcia, J. F., Harris, A. L. & Banham, A. H. (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse, Journal of Clinical Oncology. 24, 5373–5380.CrossRefGoogle Scholar
- 30.Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., Zhu, Y., Wei, S., Kryczek, I., Daniel, B., Gordon, A., Myers, L., Lackner, A., Disis, M. L., Knutson, K. L., Chen, L. & Zou, W. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nature medicine. 10, 942–949.CrossRefGoogle Scholar
- 31.Fu, J., Xu, D., Liu, Z., Shi, M., Zhao, P., Fu, B., Zhang, Z., Yang, H., Zhang, H., Zhou, C., Yao, J., Jin, L., Wang, H., Yang, Y., Fu, Y. X. & Wang, F. S. (2007) Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients, Gastroenterology. 132, 2328–2339.CrossRefGoogle Scholar